Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,816	5,205	7,738	5,637	6,483	8,252
Market Cap Growth	-6.75%	-32.74%	37.27%	-13.05%	-21.44%	-
Enterprise Value	5,366	5,445	7,421	5,342	6,161	7,991
Last Close Price	11.90	12.63	18.08	13.06	15.03	18.98
PE Ratio	29.78	18.99	26.44	28.01	42.58	87.84
Forward PE	-	13.81	26.53	-	-	-
PS Ratio	2.77	2.43	4.73	4.69	6.91	13.09
PB Ratio	3.11	3.26	4.53	4.55	6.28	8.40
P/TBV Ratio	6.62	6.88	11.37	5.81	6.41	8.51
P/FCF Ratio	129.12	84.12	46.07	32.51	50.27	715.14
P/OCF Ratio	70.65	48.61	27.97	19.22	41.82	130.48
EV/Sales Ratio	3.09	2.54	4.54	4.45	6.56	12.68
EV/EBITDA Ratio	19.09	13.54	24.44	24.24	37.78	70.73
EV/EBIT Ratio	30.13	16.58	27.77	26.11	40.56	76.20
EV/FCF Ratio	143.86	88.00	44.18	30.81	47.77	692.48
Debt / Equity Ratio	0.52	0.38	0.33	0.17	0.19	0.20
Debt / EBITDA Ratio	2.87	1.50	1.83	0.93	1.23	1.77
Debt / FCF Ratio	21.65	9.81	3.30	1.19	1.55	17.33
Asset Turnover	0.59	0.70	0.69	0.75	0.71	0.63
Inventory Turnover	1.67	2.63	3.20	3.64	4.07	4.14
Quick Ratio	1.06	1.16	1.56	1.94	2.79	3.30
Current Ratio	1.45	1.46	1.78	2.14	3.05	3.49
Return on Equity (ROE)	9.67%	16.94%	20.01%	16.91%	14.76%	11.51%
Return on Assets (ROA)	3.77%	6.71%	7.05%	7.94%	7.13%	6.59%
Return on Invested Capital (ROIC)	7.85%	16.91%	19.22%	25.16%	21.45%	14.78%
Return on Capital Employed (ROCE)	9.50%	16.80%	12.80%	16.10%	14.50%	10.50%
Earnings Yield	3.34%	5.27%	3.78%	3.57%	2.35%	1.14%
FCF Yield	0.77%	1.19%	2.17%	3.08%	1.99%	0.14%
Dividend Yield	2.86%	2.69%	1.11%	0.77%	-	1.32%
Payout Ratio	100.07%	37.97%	17.40%	4.43%	72.37%	-
Buyback Yield / Dilution	3.85%	0.79%	-0.36%	0.19%	-5.14%	-5.90%
Total Shareholder Return	6.69%	3.48%	0.75%	0.96%	-5.14%	-4.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.